Submit Deal

BIOMERIEUX SA

Summary

bioMérieux is a diagnostic systems, reagents, software and services provider.

Deals Overview

Total Deals4

Valued Deals2

Total Value£ 163 M

Avg. Deal Size£ 81 M

Market Context

Senior Management

Pierre Boulud
CEO
Alexandre Merieux
CEO and Chairman
Guillaume Bouhours
CFO

Sort

04 Apr 2018|United States|Biotechnology

Target: ASTUTE MEDICAL INC

Bidder: BIOMERIEUX SA

1 Service Providers

1 Target

1 Dealmakers

1 Target

n/a

Value

12 Apr 2022|United States|Pharmaceuticals

Target: SPECIFIC DIAGNOSTICS

Bidder: BIOMERIEUX SA

4 Service Providers

2 Target | 2 Bidder

6 Dealmakers

1 Target | 5 Bidder

n/a

Value

19 Oct 2023|United Kingdom|Biotechnology

Target: OXFORD NANOPORE TECHNOLOGIES

Bidder: BIOMERIEUX SA

3 Service Providers

1 Target | 2 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 70 M

Value

13 Jan 2025|Norway|Medical Equipment

Target: SPINCHIP

Bidder: BIOMERIEUX SA

3 Service Providers

2 Target | 1 Bidder

12 Dealmakers

10 Target | 2 Bidder

£ 92 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Senior Management

Pierre Boulud
CEO
Alexandre Merieux
CEO and Chairman
Guillaume Bouhours
CFO